Literature DB >> 23963945

Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometry.

Theodoros A Koutroukides1, Julian A J Jaros, Bob Amess, Daniel Martins-de-Souza, Paul C Guest, Hassan Rahmoune, Yishai Levin, Mike Deery, Philip D Charles, Svenja Hester, Arnoud Groen, Andy Christoforou, Julie Howard, Nick Bond, Sabine Bahn, Kathryn S Lilley.   

Abstract

Blood serum is one of the easiest accessible sources of biomarkers and its proteome presents a significant parcel of immune system proteins. These proteins can provide not only biological explanation but also diagnostic and drug response answers independently of the type of disease or condition in question. Shotgun mass spectrometry has profoundly contributed to proteome analysis and is presently considered as an indispensible tool in the field of biomarker discovery. In addition, the multiplexing potential of isotopic labeling techniques such as iTRAQ can increase statistical relevance and accuracy of proteomic data through the simultaneous analysis of different biological samples. Here, we describe a complete protocol using iTRAQ in a shotgun proteomics workflow along with data analysis steps, customized for the challenges associated with the serum proteome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963945     DOI: 10.1007/978-1-62703-589-7_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients.

Authors:  Xiuying Zhang; Haidan Sun; Sanjoy K Paul; Quanhui Wang; Xiaomin Lou; Guixue Hou; Bo Wen; Linong Ji; Siqi Liu
Journal:  Clin Proteomics       Date:  2017-05-17       Impact factor: 3.988

2.  Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.

Authors:  Stefan Tenzer; Petra Leidinger; Christina Backes; Hanno Huwer; Andreas Hildebrandt; Hans-Peter Lenhof; Tanja Wesse; Andre Franke; Eckart Meese; Andreas Keller
Journal:  Oncotarget       Date:  2016-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.